Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 13

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 13
---
 up to $100,000,000, from time to
time at prices and on terms to be determined by market conditions at the time of the offering. This prospectus provides you with a general
description of the securities we may offer. Each time we offer a type or series of securities under this prospectus, we will provide a
prospectus supplement that will describe the specific amounts, prices and other important terms of the securities, including, to the extent
applicable:

| · | designation or classification; |

| 5 |

| · | aggregate principal amount or aggregate offering price; |

| · | maturity, if applicable; |

| · | rates and times of payment of interest or dividends, if any; |

| · | redemption, conversion or sinking fund terms, if any; |

| · | voting or other rights, if any; and |

| · | conversion or exercise prices, if any. |

The prospectus supplement
also may add, update or change information contained in this prospectus or in documents we have incorporated by reference into this prospectus.
However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is
not registered and described in this prospectus at the time of its effectiveness.

We may sell the securities
directly to investors or to or through agents, underwriters or dealers. We, and our agents or underwriters, reserve the right to accept
or reject all or part of any proposed purchase of securities. If we offer securities through agents or underwriters, we will include in
the applicable prospectus supplement:

| · | the names of those agents or underwriters; |

| · | applicable fees, discounts and commissions to be paid to them; |

| · | details regarding over-allotment options, if any; and |

| · | the net proceeds to us. |

This prospectus may not be used to consummate a sale of any securities unless it is accompanied by a prospectus supplement.

| 6 |

<div align='center'>RISK FACTORS</div>

Investing in our securities involves significant risk. The prospectus supplement applicable to each offering of our securities will contain a discussion of the risks applicable to an investment in the company. Prior to making a decision about investing in our securities, you should carefully consider the specific factors discussed under the heading “Risk Factors” in the applicable prospectus supplement, together with all of the other information contained or incorporated by reference in the prospectus supplement or appearing